An Open Label Trial of TMC114/RTV in HIV-1 Infected Treatment Experienced Subjects.

Trial Profile

An Open Label Trial of TMC114/RTV in HIV-1 Infected Treatment Experienced Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jul 2014

At a glance

  • Drugs Antiretrovirals; Darunavir; HIV protease inhibitors; Ritonavir
  • Indications HIV-1 infections
  • Focus Registrational; Therapeutic Use
  • Acronyms POWER-3
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 12 May 2009 Planned number of patients changed from 450 to 555 as reported by ClinicalTrials.gov.
    • 12 May 2009 Planned number of patients changed from 450 to 555 as reported by ClinicalTrials.gov.
    • 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top